Elanco Animal Health Market Cap ($11.05 Billion)
Market Cap & Net Worth: Elanco Animal Health (ELAN)
Elanco Animal Health market cap. Elanco Animal Health (NYSE:ELAN) has a market capitalization of $11.05 Billion ($11.05 Billion) as of October 30, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2021 globally and #764 in its home market, demonstrating a 3.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elanco Animal Health's stock price $23.24 by its total outstanding shares 499449583 (499.45 Million).
Elanco Animal Health Market Cap History (2018–2026)
Elanco Animal Health market cap history from 2018 to 2026. Data shows change from $15.75 Billion to $11.61 Billion (-5.25% CAGR). Check ELAN stock price for real-time trading data and today's change.
Index Memberships
Elanco Animal Health is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Pharmaceutical
DRG
|
$3.44 Trillion | 0.32% | #16 of 24 |
Weight: Elanco Animal Health's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Elanco Animal Health Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elanco Animal Health's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see ELAN cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
2.40x
Elanco Animal Health's market cap is 2.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $15.75 Billion | $3.07 Billion | $86.50 Million | 5.13x | 182.05x |
| 2019 | $14.71 Billion | $3.07 Billion | $67.90 Million | 4.79x | 216.62x |
| 2020 | $15.32 Billion | $3.27 Billion | -$560.10 Million | 4.68x | N/A |
| 2021 | $14.17 Billion | $4.76 Billion | -$483.00 Million | 2.98x | N/A |
| 2022 | $6.10 Billion | $4.41 Billion | -$78.00 Million | 1.38x | N/A |
| 2023 | $7.44 Billion | $4.42 Billion | -$1.23 Billion | 1.68x | N/A |
| 2024 | $6.05 Billion | $4.44 Billion | $338.00 Million | 1.36x | 17.89x |
| 2025 | $11.30 Billion | $4.71 Billion | -$232.00 Million | 2.40x | N/A |
Competitor Companies of ELAN by Market Capitalization
Companies near Elanco Animal Health in the global market cap rankings as of October 30, 2026. See ELAN equity to assets ratio to understand what proportion of total assets are financed by equity.
Key companies related to Elanco Animal Health by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Elanco Animal Health (2018–2026)
Market capitalization of Elanco Animal Health from 2018 to today. Between 2018 and today, Elanco Animal Health's market cap moved from $15.75 Billion to $ 11.61 Billion, with a yearly change of -5.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.61 Billion | +2.70% |
| 2025 | $11.30 Billion | +86.87% |
| 2024 | $6.05 Billion | -18.72% |
| 2023 | $7.44 Billion | +21.93% |
| 2022 | $6.10 Billion | -56.94% |
| 2021 | $14.17 Billion | -7.47% |
| 2020 | $15.32 Billion | +4.14% |
| 2019 | $14.71 Billion | -6.60% |
| 2018 | $15.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Elanco Animal Health was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.05 Billion USD |
| MoneyControl | $11.05 Billion USD |
| MarketWatch | $11.05 Billion USD |
| marketcap.company | $11.05 Billion USD |
| Reuters | $11.05 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more